lol hahaha I seriously laughed 2 minutes

good lord you just need a new enemy every 3 hours. I went over your post over the last 2 years and you are non-stop lashing out to everyone and anyone who disagrees the slightest with you. You really should join anger management combined with some powerful medication. You really have serious issues dude. You seriously are a danger to yourself and people around you. GET HELP!

Dennis the menace. That's a kids show right Good grief how old are you (I mean the number of years that have passed since you were born, not mentally, mentally I estimate you at 8) are you 12? 13?
Dennis the menace LMAO last time I heard something like that I was 12

when you are a loser trader it is best to stop trading. My best advice for you is dont quit your day job

Every poster has 15 minutes time to edit a post when he she accidentally posts something.
What counts is the final post and that was without that part as you can find here
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172876605

But leave it to that frustrated douchebag to twist the words I never used in my final post
The frustration of Anavex runs so high here that now what someone said in an initial post prior to the final post is of life-threatening importance.

no, I think someone is really frustrated. the sad thing is he thinks that lashing out at other posters will change his financial situation.

wow what a comeback. I'm stunned, did you ask your Mommy what you should write next to the mean person on the internet?
good for you. Now Im going back to make some real money dont be late for your McDonald's shift now. Dont quit your day job!

No you didn't you are making shit up all the time here, loser

lol I will post and stay here as long as I want. Im looking forward to having many pleasant post-exchanges with you hahaha

ooh you are so frustrated about Anavex. How much money did you lose so far? Come on tell us 2 months' salary so $ 2000? 4-month salary so $ 4000
Can't pay the rent to Mommy for you basement anymore ooooh that sucks

hahahahaha

I have never said that asswhipe I said this: "Its all about present and future market cap." you added that part and now pretending I said that because you are a loser

link to the post where I said that?
Anyway for your investment ABC: market cap = O/S x stock price


here is my post https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172876605

This really is a silly assumption.

Its all about present and future market cap. NWBO's market cap is at present around $1 billion (and a week ago $600 million)
I predict a future market cap for NWBO based on approval for GBM of at least $30 billion, That a x30 bagger from today and x50 if you (as I have) had invested when NWBO's market cap was 600 million (provided NWBO will not dilute much more which I expect).

Unless of course, you think an x50 bagger is a limit appreciation in value.
Now Anavex may very well return a similar return however the risk of that happening is for reasons described here by several other posters much more unlikely than NWBOs future return

you really are a loser hahahahaha what a loser

Why do you ask me? Google it yourself how the market cap of a listed company is calculated. Please report to your elementary school teacher for basic mathematics.

You really are a dumb ass. First, keep denying AVXL changed endpoints then you ask me how a market cap is calculated. I suggest that biotech investment is not for you dummy.

Last-minute changes lead to mixed response for Anavex’s blarcamesine
https://www.clinicaltrialsarena.com/comment/mixed-response-anavexs-blarcamesine/

reality bites I know I have been there

Yes submission of the MAA with the MHRA is around the corner. However, I believe that MHRA approval in November is a little too optimistic. I am counting on the standard 3 months if the MHRA does not pull an RFI (which I do not expect).

I am convinced NWBO will outpace AVXL over the next 12 months

Im referring to the SAP "This could mean the FDA-bought-in Anavex SAP etc" reread my previous post.

If an investor is not aware of what the difference is between the SPA and the Statistical Analysis Plan then that person should not invest in non-revenue biotechs. I am referring to the Statistical Analysis Plan otherwise I would have mentioned the SPA. As I have said here a few times before I find the way in which Anavex has analyzed and presented the data and their shifted endpoints based on what they are planning to file a request for accelerated approval highly questionable.So doubtful SAP IMO. Also as I have said its very unclear to me if the FDA has agreed on Anavex's new endpoints.
Im not sure if you understand the difference between the two because from my previous post, I could have only referred to the SAP.

Of course, Anavex already had several Special Protocol Assessment meetings with the FDA to agree on the design and size of their clinical trials. However, now Anavex has, after they post hoc became aware of what the data showed, changed SAP and endpoints most likely without FDA meetings. That to me is a big red flag.

I know that most likely next is Rett. As I have said my personal investment strategy is to ONLY invest in nonrevenue with a scientifically proven drug prior to FDA approval. Anavex does not have that yet, NWBO does have that. Yes, that could mean I may miss the first stock price increase after topline data is released but over the years I experienced that after that first rise in stock price, the stock price will drop again and that is, if the data is convincing, I will buy in anticipation of approval. I rather have a 200% return on a scientifically derisked biotech stock prior to approval than 500% on a scientifically binary biotech stock. To me, FDA approval is already risky enough by its own standards. Look for example at Outlook Therapeutics. They reported they met their endpoints in the TLD PR. Still, the FDA declined approval because among other a lack of substantial evidence.

My advice in my previous post is to wait until after MHRA approval for DCVAXL which I expect half January or before to arrive. That plus some other expected news (such as news about their announced combo trials with upfront payments) should turn NWBO into a minimal x5 bagger so around $5. I can't make any promises for the next few weeks but we are in a nice uptrend which I do not expect to end. UK approval is a given.

I too will buy back into Anavex again on the condition that they have a more clear path for approval. This could mean the FDA-bought-in Anavex SAP for an AD P3 trial on which they are likely to be approved or a journal article outlining how they got the assumption they have met the endpoints. Im not gambling on an AA for AD. If that means I will miss a big bang in AVXL stock in the IMO highly unlikely situation that there will be AA then so be it. Im only investing in nonrevenue biotech companies with a scientifically validated path forward for their drug.

deal lets do that

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172827613

since I said this on Sept 15th NWBO stock gained 45% and Anavex dropped -13%
Other than that Im not to be trusted lol

no matter how many times you provide overwelhming evidence exwanneassh the IT guy from Georgia will never admit to anything.
exwanneassh reminds me of Shaggy

She even caught me on camera (It wasn't me)
She saw the marks on my shoulder (It wasn't me)
Heard the words that I told her (It wasn't me)

ooh a generic term sure sure sure the IT guy from Georgia is so trustworthy.
Ex question should I sell my 475K NWBO shares then?

You are absolutely right this whole instant approval for tissue-agnostic tumors is a figment of ATL's imagination and not based on any FDA regulation outlined here https://www.fda.gov/media/162346/download

Its Atlanta's recurring fantasy based on ChatGTP research.

a euhm....? liar lol

sorry I dont understand gibberish

agreed

That article is from Feb 2022.

The point is the trouble that Anavex is in to get AA for this AD trial.
-Changed endpoints late-stage
- No bought-in clear SAP, changing the SAP by every next PR
-Missing a coprimary endpoint which doesn't support the met all primary and secondary endpoints claim (for making that previous statement I personally see Anavex being held legally liable but that is for another discussion)
- Controversial in the manner in which they statistically analyzed the data within the last PR mathematical errors.
- Post hoc data digging

If Anavex's new SAP they have apprearently now decided on since Nov 2022, is accepted by the FDA then their Phase 3 trial has a good chance of being successful.

? sorry I dont understand gibberish. The rest of your post is pure frustration and fantasy.

I have no position in Anavex short or long. But will buy into Anavex after their new SAP as what they appear now (since yesterday's PR) are going for has been bought in by the FDA and they started their P3 AD trial.

No everything that does not fit your investment thesis is FUD even reality, according to you.

yes lots of questions remain unanswered.

Ok

https://seekingalpha.com/news/3794168-anavex-down-16-as-criticism-on-changing-endpoints-in-late-stage-trial-mounts

mine too

? gibberish

Anavexs SAP and original endpoints have not been bought in by the FDA hence their change in PR language and data presentation from their last one and the one before that. Why do you think the SP reacts accordingly with what Im saying?

This MB is not for anyone to influence anyone else. Its to exchange ideas and discuss the ongoing Anavex trial. My advice to you and any other MB poster is not to be influenced by any other poster but to conduct your own due diligence. Good luck with your investment endeavor.

Just because someone does not post too many times on the Anavex board does not make that person incorrect.
The ongoing OLE will only confirm yesterday called surrogate new endpoints. You can make the illations from 100 datasets or 1000 datasets it doesnt matter if these datasets point to the same statistical conclusion of a non-existing SAP. The problem/challenge Anavex is facing right now is best described in this post

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172827280

No its a genuine investment tip for retail investors. Call me out in 3 to 6 months from now and call me out now if anything I said about Anavex is not based on common sense.

Or are you not in it to make money? Also, you would insult my intelligence if I was under the impression that 5 new retail shareholders would do anything for NWBO stock price. NWBO will see a huge investor between now and 3-4 months and it's not going to be 5 formal Anavex shareholders.

But thank you for contributing this much power to me ;)

I agree with your analysis. Thank you for your reply

I understand its difficult to cope with the situation Anavex finds its self in at present. My recommendation is to sell AVXL and buy all NWBO shares you can get your hands on. You can thank me in 3 to 6 months.

After an incredible return on NWBO shares, you can sell some of those and buy a small portion back in Anavex. I do believe they will get ADD approved if their SAP for the P3 trial is bought in by the FDA and in a few yeard after their P3 trial has been concluded.

agreed

lol that is the text in a tattoo to live by. Ps do consider the option that Dave is a family name